IRIDEX -Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates

Iridex (IRIX) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of$ 0.12. This compares to loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -33.33%. A quarter ago, it was expected that this medical laser company would post a loss of$ 0.12 per share when it actually produced a loss of $0.21, delivering a surprise of -75%. Over the last four quarters, the company has su ...